Treeline Biosciences, Inc.
Clinical trials sponsored by Treeline Biosciences, Inc., explained in plain language.
-
New drug targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called TLN-372 in people with advanced solid tumors that have a specific genetic change called a KRAS mutation. The main goals are to check the drug's safety and how well it fights tumors, both alone and with other cancer drugs. About 240 a…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 11:01 UTC
-
New hope for tough lymphomas: experimental drug TLN-121 enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called TLN-121, alone or with other lymphoma treatments, in about 180 adults whose Non-Hodgkin Lymphoma has returned or not responded to prior therapy. The main goals are to check safety, find the right dose, and see if the drug shrinks tum…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for tough lymphoma: experimental drug TLN-254 enters human testing
Disease control Recruiting nowThis early-stage trial tests an experimental drug called TLN-254 in about 50 adults with T-cell lymphoma that has returned or not responded to prior therapy. The main goal is to see if the drug can shrink tumors or make them disappear. Researchers will also monitor side effects a…
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated May 18, 2026 11:59 UTC